Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Andres-Jan Schrader"'
Autor:
Rouvier Al-Monajjed, Peter Albers, Johanna Droop, Dominik Fugmann, Joachim Noldus, Rein-Jüri Palisaar, Manuel Ritter, Jörg Ellinger, Philipp Krausewitz, Michael Truß, Boris Hadaschik, Viktor Grünwald, Andres-Jan Schrader, Philipp Papavassilis, Nicole Ernstmann, Barbara Schellenberger, Anna Moritz, Christoph Kowalski, Martin Hellmich, Pierce Heiden, Anna Hagemeier, Dirk Horenkamp-Sonntag, Markus Giessing, Luis Pauler, Sebastian Dieng, Maria Peters, Günter Feick, André Karger, PRO-P study group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-17 (2024)
Abstract Background With over 65,000 new cases per year in Germany, prostate cancer (PC) is the most common cancer in men in Germany. Localized PC is often treated by radical prostatectomy and has a very good prognosis. Postoperative quality of life
Externí odkaz:
https://doaj.org/article/56a2ad8a0f324aa3895b7dffee7b343e
Autor:
Stefanie Zschäbitz, Marie Mikuteit, Christine Stöhr, Edwin Herrmann, Iris Polifka, Abbas Agaimy, Lutz Trojan, Philipp Ströbel, Frank Becker, Christian Wülfing, Peter Barth, Michael Stöckle, Michael Staehler, Christian Stief, Axel Haferkamp, Markus Hohenfellner, Stefan Duensing, Stephan Macher-Göppinger, Bernd Wullich, Joachim Noldus, Walburgis Brenner, Frederik C. Roos, Bernhard Walter, Wolfgang Otto, Maximilian Burger, Andres Jan Schrader, Arndt Hartmann, Franziska Erlmeier, Sandra Steffens
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Background Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and checkpoint
Externí odkaz:
https://doaj.org/article/f48c4647fe714704ac7639eb9dc60db9
Autor:
Renata Poteska, Kambiz Rahbar, Axel Semjonow, Andres Jan Schrader, Martin Boegemann, Katrin Schlack
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background In patients with bone metastatic castration-resistant prostate cancer (bmCRPC) on systemic treatment, it is difficult to differentiate between continuous rise of prostate specific antigen (PSA) representing progression, and PSA-su
Externí odkaz:
https://doaj.org/article/3d2e1693769d460abe8aac23c4640ec9
Autor:
Dimo Dietrich, Lutz Trojan, Niklas Klümper, Damian J Ralser, Romina Zarbl, Glen Kristiansen, Marieta Toma, Manuel Ritter, Michael Hölzel, Jörg Ellinger, Markus Eckstein, Danijel Sikic, Katrin Schlack, Andres Jan Schrader, Marc Rehlinghaus, Michèle J Hoffmann, Günter Niegisch, Annemarie Uhlig, Julie Steinestel, Konrad Steinestel, Ralph M Wirtz, Sebastian Strieth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/6e349fc1c30b4c718dcf71148fb36faf
Autor:
Lisa Traeger, Ines Ellermann, Helene Wiethoff, Janina Ihbe, Inka Gallitz, Maria Eveslage, Rudolf Moritz, Edwin Herrmann, Andres Jan Schrader, Andrea U. Steinbicker
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Cancer is a life-threatening disease that causes every fourth death. It is often hard to determine the time point of progression. Therefore, biomarkers for cancer entities that indicate disease progression or aggressiveness and th
Externí odkaz:
https://doaj.org/article/95df54a15ac546f198fd1e147aac8024
Autor:
Stefanie Zschäbitz, Franziska Erlmeier, Christine Stöhr, Edwin Herrmann, Iris Polifka, Abbas Agaimy, Lutz Trojan, Philipp Ströbel, Frank Becker, Christian Wülfing, Peter Barth, Michael Stöckle, Michael Staehler, Christian Stief, Axel Haferkamp, Markus Hohenfellner, Stephan Macher-Göppinger, Bernd Wullich, Joachim Noldus, Walburgis Brenner, Frederik C. Roos, Bernhard Walter, Wolfgang Otto, Maximilian Burger, Andres Jan Schrader, Yvonne Mondorf, Arndt Hartmann, Philipp Ivanyi, Sandra Steffens
Publikováno v:
Journal of Cancer. 13:1706-1712
Prostate specific membrane antigen (PSMA) is an emerging diagnostic and therapeutic target in prostate cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3e7acba0e02fd5f052bf0abe022c8d
https://doi.org/10.7150/jca.63509
https://doi.org/10.7150/jca.63509
Autor:
Neele Wüstmann, Konstantin Seitzer, Verena Humberg, Julia Vieler, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Stefan Duensing, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann, Katrin Schlack
Background Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the connection between AR full leng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e67a78e73725fa980f1f5688380731
https://opus.bibliothek.uni-augsburg.de/opus4/files/105701/s40364-023-00481-w.pdf
https://opus.bibliothek.uni-augsburg.de/opus4/files/105701/s40364-023-00481-w.pdf
Autor:
Martin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, Joachim Gerß, Julie Steinestel, Axel Semjonow, Andres Jan Schrader, Laura-Maria Krabbe
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161959 (2016)
Even though the exact mechanism is largely unknown until now, statins are supposed to improve survival outcomes in various malignancies. For prostate cancer however, statins are known to compete with dehydroepiandrosterone (DHEAS) for the transport i
Externí odkaz:
https://doaj.org/article/ed44161534824da6953c9f0fcfb31c9b
Autor:
Marie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, Edwin Herrmann, Iris Polifka, Abbas Agaimy, Lutz Trojan, Philipp Ströbel, Frank Becker, Christian Wülfing, Peter Barth, Michael Stöckle, Michael Staehler, Christian Stief, Axel Haferkamp, Markus Hohenfellner, Stephan Macher-Göppinger, Bernd Wullich, Joachim Noldus, Walburgis Brenner, Frederik C. Roos, Bernhard Walter, Wolfgang Otto, Maximilian Burger, Andres Jan Schrader, Arndt Hartmann, Sandra Steffens, Franziska Erlmeier
Publikováno v:
Pathology, research and practice. 231
Claudins are promising biomarkers for diagnosis and prognosis or targets for treatment. They play a major role in signal transduction and are important in nearly all aspects of tumorigenesis. Claudin 6 is a member of the claudin family and is part of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c80b450a416071bee2c1a1f94b71a88
https://pubmed.ncbi.nlm.nih.gov/35180650
https://pubmed.ncbi.nlm.nih.gov/35180650
Autor:
Kambiz Rahbar, Mark Kidd, Konstantin Egon Seitzer, Andres Jan Schrader, Martin Boegemann, Irvin Mark Modlin
Publikováno v:
Journal of Clinical Oncology. 41:386-386
386 Background: A critical clinical concern after radical prostatectomy for prostate cancer (PCa) is the timely identification of residual disease. Recurrent disease (biochemical recurrence: BCR) develops in approximately 30% of radical prostatectomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b69df6305683e9b54d8d0edee1ee4fa
https://doi.org/10.1200/jco.2023.41.6_suppl.386
https://doi.org/10.1200/jco.2023.41.6_suppl.386